Microbix Biosystems Inc T.MBX

Ramping up vtm production

[RazeKreations]

All the vtm inventory has been sold and production is going to be doubled as quick as possible current production is 60000 per week. Once automation is done it will be 60000 per day and sales to other customers can ramp up. Lots of demand

[wizzdumb]

Yes, great news, and they only shut down production briefly because of expansion work. Now it's just down to getting the automation finished and ramped.  Cameron was asked for catalysts for growth for 2022 and chose to include Kinlytic in his top three, to me that indicates it's basically a done deal. Prepare accordingly. 

[Mbxwatcher]

Excellent call.  Few surprises. looks like Q1 will be strong top and bottom line, as they got the VTM order in under the wire and the non cash charge was dealt with in last years results.  It had been looking like Q1 would be weak, but that no longer seems to be the case Sounds like major QAPS deals with Test manufacturers are almost imminent. When asked whether we would see

[prophetoffacts]

This post has been removed in accordance with Community Policy

[rjc7]

Can someone please post a link to the call.  I was unable to attend this one.  Thanks

[RazeKreations]

https://youtu.be/kD9PqUG9Zq0

[lscfa]

Any revenue or ebitda guidance given?

[RazeKreations]

No nothing specific. Vtm sales maxed out and will be able to double that very soon with current methods and once automation is completed sales volumes will increase substantially with many opportunities across Canada and many opportunities outside of the country after that. Demand is there, just need to catch up on production. Then the demand for Qaps is growing worldwide. Antigens are stable with

[Mbxwatcher]

Nothing i would consider guidance. He talked more about drivers......... Meaningful revenue growth in QAPS, and VTM steady as she goes with Antigens. He implied proportionate growth in EBITDA by way of margins going into the 60's for both products. Sounds like Q1 will be meaningfully better than Q1 last year. But I really didnt get the sense of any guidance that could be put down on paper.

[prophetoffacts]

This post has been removed in accordance with Community Policy

[wizzdumb]

In the previous Adelaide update Cameron says potential is $4M per month for QAPs and same for VTM once expansion completed. So $8M per month. That's how you get to $100M per year. 

[Mbxwatcher]

yes, also pretty sure in both cases they need the automation to be able to hit those revenue numbers. I think what i was most pleased with at least on the QAPS side is he was virtually certain they would be signing those deals in the very near future.

[wizzdumb]

For sure it is, completing the automation projects as soon as possible is the key to unlocking all of this potentital business. They know that and sounds like it's going well so far. Once it's done it sounds like they have the customers lining up for both. If they can pull off a Kinlytic deal as well it will be a very, very good year. 

[Mbxwatcher]

just made this years TFSA contribution..............Microbix :)

[tasman99]

HOPE YOU AREN'T tOO EARLY slip sliding again.

[rjc7]

All of my MBX shares are split between my wife's and my TFSA. Great way to accumulate wealth tax free with the growth potential.  I came across an interesting YouTube on one of the TFSA mistakes many of us have made (myself included) when setting up our accounts with regards to beneficiaries. He mentions 5 but the first mistake is the one that prompted me to change how the beneficiary was